2026 Annual Meeting | Industry Therapeutic Update from Novartis Pharmaceuticals: BTK in Neuroinflammation with a Focus on Multiple Sclerosis

Date Saturday 04/18/26

Time 11:45 AM - 12:45 PM CDT Add To Calendar

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Industry Therapeutic Update

Topic(s) Multiple Sclerosis

Learning Objectives This program will explore the role of the Bruton´s tyrosine kinase (BTK) enzyme in the pathogenesis of neuroinflammation and its role in multiple sclerosis (MS), focusing on underlying mechanisms in B cells and microglia/macrophages.

CME Available No CME available

Event Timeline
11:45 AM - 12:45 PM CDT	Speaker	Industry Therapeutic Update from Novartis Pharmaceuticals: BTK in Neuroinflammation with a Focus on Multiple Sclerosis

��ɫ��

��ɫ��